Table 1.
Variable | Means or [N] % (95% CI) by genotype | P heterogeneitya | ||
QQ N = 1669 | QR N = 1326 | RR N = 271 | ||
Dichotomous variables | ||||
Myocardial infarction (MI) | [53] 3.2 (2.4, 4.3) | [46] 3.5 (2.6, 4.8) | [12] 4.4 (2.3, 7.6) | 0.51 |
Angina (but no history of MI) | [186] 11.1 (9.7, 12.8) | [165] 12.4 (10.7, 14.3) | [18] 6.6 (4.0, 10.3) | 0.13 |
Any CHD (MI or angina) | [239] 14.3 (12.7, 16.1) | [211] 15.9 (14.1, 18.0) | [30] 11.1 (7.6, 15.4) | 0.14 |
Diabetes at baseline | [75] 4.5 (3.6, 5.6) | [70] 5.3 (4.3, 6.7) | [12] 4.4 (2.5, 7.6) | 0.61 |
Current smoker | [189] 11.3 (9.9, 12.9) | [163] 12.3 (10.6, 14.1) | [22] 8.1 (5.4, 11.9) | 0.12 |
Ever smoker | [746] 44.6 (42.2, 47.0) | [596] 44.9 (42.3, 47.6) | [116] 42.9 (37.1, 48.8) | 0.82 |
Adult manual social class | [964] 57.8 (55.4, 60.2) | [725] 54.7 (52.0, 57.3) | [157] 57.9 (51.9, 63.6) | 0.20 |
Childhood manual social class | [1334] 79.9 (77.9, 81.8) | [1075] 81.1 (78.9, 83.1) | [219] 81.0 (75.9, 85.2) | 0.72 |
On statin | [126] 7.5 (6.4, 8.9) | [95] 6.9 (5.6, 8.3) | [25] 9.2 (6.3, 13.2) | 0.41 |
Continuous variables | ||||
Age | 68.8 (68.6, 69.1) | 68.8 (68.5, 69.1) | 68.9 (68.3, 68.3) | 0.91 |
HOMAc | 1.64 (1.59, 1.70) | 1.72 (1.66, 1.79) | 1.69 (1.56, 1.82) | 0.15 |
Total cholesterol | 6.64 (6.58, 6.70) | 6.65 (6.58, 6.72) | 6.61 (6.46, 6.75) | 0.85 |
HDLc | 1.65 (1.63, 1.67) | 1.65 (1.63, 1.68) | 1.70 (1.65, 1.76) | 0.18 |
LDLc | 4.15 (4.09, 4.20) | 4.15 (4.09, 4.21) | 4.02 (3.89, 4.16) | 0.21 |
Triglyceridesc | 1.67 (1.64, 1.71) | 1.69 (1.65, 1.73) | 1.71 (1.62, 1.81) | 0.73 |
Systolic BP | 148.3 (147.1, 149.5) | 146.0 (144.6, 147.3) | 150.4 (147.4, 153.4) | 0.006 |
Diastolic BP | 79.9 (79.3, 80.4) | 78.9 (78.3, 79.6) | 80.3 (78.9, 81.8) | 0.05 |
BMI | 27.6 (27.3, 27.8) | 27.6 (27.4, 27.9) | 27.6 (27.0, 28.2) | 0.96 |
WHR | 0.817 (0.814, 0.821) | 0.821 (0.817, 0.824) | 0.826 (0.818, 0.834) | 0.11 |
a χ2 for dichotomous variables and ANOVA for continuous variables bOccurrence of a new CHD event (death from CHD, new diagnosis of MI / angina, new CABG or angioplasty). All other characteristics are from baseline measures cGeometric means